Eating disorders, sleep, ADHD, and more: PNCB's fourth edition of all new in-depth psychopharmacology CE includes 12 journal articles for your references. Topics covered in this must-take module include:

• Potential cardiovascular complications of stimulant medications.
• Nonstimulant alternatives for the treatment of ADHD.
• Medication options for children with ADHD and co-occurring Tourette’s syndrome, autism spectrum disorder, or substance use disorders.
• Pediatric insomnia and recommend therapies to improve sleep.
• Therapies for restless leg syndrome in children.
• Strategies for treatment of serotonin syndrome.
• Pharmacologic treatment of eating disorders for children and adolescents with co-existing mental health disorders.
• Medications used for the management of explosive behaviors, bipolar disorder and schizophrenia in children.

For APRNs, RNs, or those familiar with pediatric pharmacology. View Content Outline

• 7.5 pharmacology contact hours accredited by NAPNAP (7.5 related to psychopharmacology) (2.5 related to controlled substances).
• Answers are due 150 days from order process date.
• 39 questions.
• What references are included?
  • 12 online PDF articles to support answering all 39 questions.

Sample Question

Q. Parents are hesitant to give their child with ADHD the recommended stimulant medication, fearing it will increase the risk of drug use and addiction when older. Important education to provide about substance use disorder (SUD) is that treatment of ADHD with stimulant medication

---

A. does not affect the risk of developing SUD.
B. is protective against the development of SUD.
C. can increase the future risk of developing SUD.
D. remains undetermined as a risk for developing SUD.